We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Expects Minimal Industry Burden from New API GMP Regs
Canada Expects Minimal Industry Burden from New API GMP Regs
November 9, 2012
Proposed good manufacturing practice (GMP) regulations will cost active pharmaceutical ingredient makers in Canada nearly $1 million dollars in initial costs and $100,000 in annual compliance, according to an analysis by Health Canada.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor